Australian oncologists question calls for universal Next-Generation Sequencing in advanced cancer

Australian oncologists have expressed doubts about a recommendation from US counterparts that next generation sequence (NGS) testing become a component of standard care for all patients with advanced cancer. In an article in JAMA Oncology they have questioned the data behind the ‘expansive’ recommendation, arguing that study findings on which they are based are ‘far ...

Already a member?

Login to keep reading.

© 2022 the limbic